Dexamethasone-cyclodextrin-polymer co-complexes in aqueous eye drops: Aqueous humor pharmacokinetics in humans

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 6, 1996, Pages 1199-1203

  Kristinsson, Jóhannes Kári ^a   Fridriksdóttir, Hafrún ^b   Thórisdóttir, Sigrídur ^a   Sigurdardóttir, Anna M ^b   Stefánsson, Einar ^a,b   Loftsson, Thorsteinn ^b  

^a Landakolsspítali ^*  (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

Author keywords

aqueous humor; corticosteroids; cyclodextrin; dexamethasone; drug penetration

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CYCLODEXTRIN; DEXAMETHASONE; EYE DROPS; POLYMER;

AQUEOUS HUMOR; ARTICLE; CATARACT; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SOLUBILITY; DRUG TISSUE LEVEL; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

ANTI-INFLAMMATORY AGENTS; AQUEOUS HUMOR; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CATARACT EXTRACTION; CELL MEMBRANE PERMEABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLODEXTRINS; DEXAMETHASONE; DRUG DELIVERY SYSTEMS; HEAT; HUMANS; METHYLCELLULOSE; OPHTHALMIC SOLUTIONS; SOLUBILITY;

EID: 0029971870     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Gordon DM. Dexamethasone in ophthalmology. Am J Ophthalmol. 1959;48:656-660.
2. Müller BW, Brauns U. Solubilization of drugs by modified β-cyclodextrins. Int J Pharmacol. 1985;26:77-88.
3. Pitha J, Milecki J, Fales H, Pannell L, Uekama K. Hydroxypropyl-β-cyclodextrin: Preparation and characterization: Effects on solubility of drugs. Int J Pharmacol. 1986;29:73-82.
4. Loftsson T, Brewster ME, Derendorf H, Bodor N. 2-hydroxypropyl-β-cyclodextrin: Properties and usage in pharmaceutical formulations. Pharm Ztg Wisw. 1991;136:5-10.
5. Szejtli J. Cyclodextrin Technology. Dordrecht: Kluwer Academic; 1988:39-43, 188-192.
6. Loftsson T, Ólafsdóttir BJ, Bodor N. The effects of cyclodextrin on transdermal delivery of drugs. Eur J Pharmacol Biopharmacol. 1991;37:30-33.
7. Usayapant A, Karara AH, Narurkar MM. Effect of 2-hydroxypropyl-β-cyclodextrin on the ocular absorption of dexamethasone and dexamethasone acetate. Pharmacol Res. 1991;12:1495-1499.
8. van Doorne H. Interactions between cyclodextrins and ophthalmic drugs. Eur J Pharmacol Biopharmacol. 1993;39:133-139.
9. Jansen T, Xhonneux B, Mesens J, Borgers M. Beta-cyclodextrins as vehicles in eye-drop formulations: An evaluation of their effects on rabbit corneal epithelium. Lens Eye Toxicity Res. 1990;7:459-468.
10. Loftsson T, Fridriksdóttir H, Thórisdóttir S, Stefánsson E. The effect of hydroxypropyl methylcellulose on the release of dexamethasone from aqueous 2-hydroxypropyl-β-cyclodextrin formulations. Int J Pharmacol. 1994;104:181-184.
11. Schoenwald RD, Harris RG, Turner D, Knowles W, Chien D-S. Ophthalmic bioequivalence of steroid/antibiotic combination formulations. Biopharm Drug Dispos. 1987;8:527-548.
12. Watson D, Noble MJ, Dutton GN, Midgley JM, Healey TM. Penetration of topically applied dexamethasone alcohol into human aqueous humor. Arch Ophthalmol. 1988;106:686-687.
13. McGhee CNJ, Watson DG, Midgley JM, Noble MJ, Dutton GN, Fern AI. Penetration of synthetic corticosteroids into human aqueous humour. Eye. 1990;4:526-530.
14. Havener WH. Corticosteroid therapy. In: Havener WH, ed. Ocular Pharmacology. 5th ed. St. Louis: CV Mosby; 1983:433-500.
15. Haynes RC, Murad F. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 7th ed. New York: MacMillan; 1985:1475-1477.